EULAR points to consider for conducting clinical trials in systemic lupus erythematosus

C. Gordon*, G. Bertsias, J. P. A. Ioannidis, J. Boletis, S. Bombardieri, R. Cervera, C. Dostal, J. Font, I-M Gilboe, F. Houssiau, T. W. J. Huizinga, D. Isenberg, C. G. M. Kallenberg, M. A. Khamashta, J-C Piette, M. Schneider, J. S. Smolen, G. Sturfelt, A. Tincani, R. Van VollenhovenD. T. Boumpas

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

34 Citations (Scopus)

Fingerprint

Dive into the research topics of 'EULAR points to consider for conducting clinical trials in systemic lupus erythematosus'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases